Login Register Cart 0
Generic placeholder image

当代阿耳茨海默病研究

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in English
Research Article

贫血与痴呆症的关联：台湾全国性的队列研究

卷 17, 期 2, 2020

页: [196 - 204] 页: 9

弟呕挨: 10.2174/1567205017666200317101516

价格: $65

conference banner
摘要

背景：除传统的风险预测因素外，贫血是否是痴呆的早期生物标志物，还需要确定。 目的：这项基于人群的队列研究旨在使用台湾国家健康保险研究数据库中的数据调查新诊断为贫血患者的痴呆风险。 方法：所有没有脑卒中住院史，除痴呆，精神病，脑外伤，大手术或失血性疾病之外均无中枢神经疾病史的新诊断贫血患者（n = 26,343）被纳入研究。还包括一组非贫血对照，根据人口统计学和合并症与贫血患者按1：4比例配对。与竞争性对照相比，竞争性风险分析用于评估贫血患者的痴呆风险。 结果：贫血患者痴呆风险调整后的亚分布危险比（SHR）为1.14（95％置信区间[CI]：1.08〜1.21，p <0.001）。与不使用铁补充剂的患者相比，使用铁补充剂的患者倾向于表现出较低的痴呆风险（调整后的SHR：0.84； 95％CI：0.75〜0.94，p = 0.002）。亚组分析显示，痴呆症与贫血之间存在正相关关系，女性，70岁及以上的女性以及无高血压，糖尿病或高脂血症的患者。 结论：当前基于人群的队列研究确定了新诊断的贫血是痴呆的危险因素，而且补充铁能够降低缺铁性贫血患者痴呆的风险。

关键词: 痴呆症，贫血，基于人群的队列研究，竞争性风险分析，亚分布危险比，载脂蛋白E4（ApoE4）。

« Previous
[1]
Prince M, Ali GC, Guerchet M, Prina AM, Albanese E, Wu YT. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther 8(1): 23-3. (2016).
[http://dx.doi.org/10.1186/s13195-016-0188-8] [PMID: 27473681]
[2]
Dyer SM, Harrison SL, Laver K, Whitehead C, Crotty M. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr 30(3): 295-309. (2018).
[http://dx.doi.org/10.1017/S1041610217002344] [PMID: 29143695]
[3]
Deckers K, van Boxtel MPJ, Schiepers OJG, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 30(3): 234-46. (2015).
[http://dx.doi.org/10.1002/gps.4245] [PMID: 25504093]
[4]
Smith JA. Exercise, training and red blood cell turnover. Sports Med 19(1): 9-31. (1995).
[http://dx.doi.org/10.2165/00007256-199519010-00002] [PMID: 7740249]
[5]
Mohanty JG, Nagababu E, Rifkind JM. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front Physiol 5: 84-4. (2014).
[http://dx.doi.org/10.3389/fphys.2014.00084] [PMID: 24616707]
[6]
Hong CT, Huang YH, Liu HY, Chiou HY, Chan L, Chien LN. Newly diagnosed anemia increases risk of Parkinson’s disease: a Population-Based Cohort Study. Sci Rep 6: 29651. (2016).
[http://dx.doi.org/10.1038/srep29651] [PMID: 27412825]
[7]
Savica R, Grossardt BR, Carlin JM, et al. Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology 73(17): 1381-7. (2009).
[http://dx.doi.org/10.1212/WNL.0b013e3181bd80c1] [PMID: 19858460]
[8]
Wu T-Y, Majeed A, Kuo KN. An overview of the healthcare system in Taiwan. London J Prim Care (Abingdon) 3(2): 115-9. (2010).
[http://dx.doi.org/10.1080/17571472.2010.11493315] [PMID: 25949636]
[9]
Cheng TM. Taiwan’s new national health insurance program: genesis and experience so far. Health Aff (Millwood) 22(3): 61-76. (2003).
[http://dx.doi.org/10.1377/hlthaff.22.3.61] [PMID: 12757273]
[10]
Little RJ, Rubin DB. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. Annu Rev Public Health 21: 121-45. (2000).
[http://dx.doi.org/10.1146/annurev.publhealth.21.1.121] [PMID: 10884949]
[11]
Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 27(12): 2037-49. (2008).
[http://dx.doi.org/10.1002/sim.3150] [PMID: 18038446]
[12]
Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 26(4): 734-53. (2007).
[http://dx.doi.org/10.1002/sim.2580] [PMID: 16708349]
[13]
Chen JH, Lin KP, Chen YC. Risk factors for dementia. J Formos Med Assoc 108(10): 754-64. (2009).
[http://dx.doi.org/10.1016/S0929-6646(09)60402-2] [PMID: 19864195]
[14]
Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement 11(6): 718-26. (2015).
[http://dx.doi.org/10.1016/j.jalz.2015.05.016] [PMID: 26045020]
[15]
Roe CM, Fitzpatrick AL, Xiong C, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 74(2): 106-12. (2010).
[http://dx.doi.org/10.1212/WNL.0b013e3181c91873] [PMID: 20032288]
[16]
Lin TM, Chen WS, Sheu JJ, Chen YH, Chen JH, Chang CC. Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study. PLoS One 13(1): e0186475 (2018).
[http://dx.doi.org/10.1371/journal.pone.0186475] [PMID: 29304089]
[17]
Chiang CJ, Yip PK, Wu SC, et al. Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan. Am J Geriatr Psychiatry 15(9): 762-71. (2007).
[http://dx.doi.org/10.1097/JGP.0b013e318050c98f] [PMID: 17623813]
[18]
Chilcot J, Guirguis A, Friedli K, et al. Depression symptoms in haemodialysis patients predict all-cause mortality but not kidney transplantation: a cause-specific outcome analysis. Ann Behav Med 52(1): 1-8. (2018).
[http://dx.doi.org/10.1007/s12160-017-9918-9] [PMID: 28762106]
[19]
Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation 133(6): 601-9. (2016).
[http://dx.doi.org/10.1161/CIRCULATIONAHA.115.017719] [PMID: 26858290]
[20]
Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41(3): 861-70. (2012).
[http://dx.doi.org/10.1093/ije/dyr213] [PMID: 22253319]
[21]
Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9(1): 119-28. (2010).
[http://dx.doi.org/10.1016/S1474-4422(09)70299-6] [PMID: 20083042]
[22]
Carmel R. Anemia and aging: an overview of clinical, diagnostic and biological issues. Blood Rev 15(1): 9-18. (2001).
[http://dx.doi.org/10.1054/blre.2001.0146] [PMID: 11333135]
[23]
Bissinger R, Bhuyan AAM, Qadri SM, Lang F. Oxidative stress, eryptosis and anemia: a pivotal mechanistic nexus in systemic diseases. FEBS J 286(5): 826-54. (2019).
[http://dx.doi.org/10.1111/febs.14606] [PMID: 30028073]
[24]
Jeong SM, Shin DW, Lee JE, Hyeon JH, Lee J, Kim S. Anemia is associated with incidence of dementia: a national health screening study in Korea involving 37,900 persons. Alzheimers Res Ther 9(1): 94. (2017).
[http://dx.doi.org/10.1186/s13195-017-0322-2] [PMID: 29212527]
[25]
Chung SD, Sheu JJ, Kao LT, Lin HC, Kang JH. Dementia is associated with iron-deficiency anemia in females: a population-based study. J Neurol Sci 346(1-2): 90-3. (2014).
[http://dx.doi.org/10.1016/j.jns.2014.07.062] [PMID: 25127441]
[26]
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 352(10): 1011-23. (2005).
[http://dx.doi.org/10.1056/NEJMra041809] [PMID: 15758012]
[27]
Nakabeppu Y, Tsuchimoto D, Furuichi M, Sakumi K. The defense mechanisms in mammalian cells against oxidative damage in nucleic acids and their involvement in the suppression of mutagenesis and cell death. Free Radic Res 38(5): 423-9. (2004).
[http://dx.doi.org/10.1080/10715760410001688348] [PMID: 15293549]
[28]
Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 85(1): 193-200. (2007).
[http://dx.doi.org/10.1093/ajcn/85.1.193] [PMID: 17209196]
[29]
Cevik B, Solmaz V, Yigitturk G, Cavusoğlu T, Peker G, Erbas O. Neuroprotective effects of erythropoietin on Alzheimer’s dementia model in rats. Adv Clin Exp Med 26(1): 23-9. (2017).
[http://dx.doi.org/10.17219/acem/61044] [PMID: 28397428]
[30]
Dehejia RH, Wahba S. Propensity score-matching methods for nonexperimental causal studies. Rev Econ Stat 84(1): 151-61. (2002).
[http://dx.doi.org/10.1162/003465302317331982]
[31]
Johnson SR, Tomlinson GA, Hawker GA, Granton JT, Feldman BM. Propensity score methods for bias reduction in observational studies of treatment effect. Rheum Dis Clin North Am 44(2): 203-13. (2018).
[http://dx.doi.org/10.1016/j.rdc.2018.01.002] [PMID: 29622292]
[32]
McAfee AT, Ming EE, Seeger JD, et al. The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy. Pharmacoepidemiol Drug Saf 15(7): 444-53. (2006).
[http://dx.doi.org/10.1002/pds.1281] [PMID: 16761308]
[33]
Prada-Ramallal G, Takkouche B, Figueiras A. Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review. BMC Med Res Methodol 19(1): 53-3. (2019).
[http://dx.doi.org/10.1186/s12874-019-0695-y] [PMID: 30871502]

Rights & Permissions Print Cite
Article Metrics
17
1
1
© 2024 Bentham Science Publishers | Privacy Policy